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The importance of RNA-protein interactions in
controlling mRNA regulation and non-coding RNA
function is increasingly appreciated. A variety of
methods exist to comprehensively define RNA-protein
interactions. We describe these methods and the
considerations required for designing and interpreting
these experiments.translation [31], and silencing of DNA repeats [32]. InIntroduction
Over the past decade there has been an increasing appre-
ciation of the importance of RNA-protein interactions in
controlling many aspects of gene regulation [1,2]. The ex-
plosion in sequencing technologies has enabled explor-
ation of the transcriptome at unprecedented depth [3].
This has led to a growing appreciation of the widespread
role of alternative messenger RNA (mRNA) splicing [4-7],
processing [8], editing [9-11] and methylation [12,13] in
generating diverse mRNAs and in controlling the stability
and translation of mRNA. Furthermore, this has led to the
identification of diverse classes of non-coding RNAs
(ncRNAs), including many thousands of long non-coding
RNAs (lncRNAs) that resemble mRNA but are not trans-
lated into proteins [14-17].
The central role of RNA-protein interactions in con-
trolling mRNA processing [1,2] and ncRNA function
[18,19] is now clear. Many proteins are known to be re-
quired for various aspects of mRNA processing [1].
These include the ubiquitously expressed serine-rich
(SR) proteins [20] and heteronuclear ribonucleoproteins
(hnRNPs) [21], as well as the cell type-specific Nova
[22], Fox [23] and Muscleblind [24] proteins, which all
play important roles in the regulation of alternative spli-
cing in different cell types [2,25,26]. Yet, precisely how
these proteins control the diversity of cell type-specific* Correspondence: mguttman@caltech.edu
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proper cellular functions of virtually all ncRNAs - in-
cluding those with catalytic roles [28,29] - depend upon
the formation of RNA-protein complexes [18,19,30].
These include classical examples such as ribosomal
RNAs, small nuclear RNAs and small nucleolar RNAs
that control translation, splicing and ribosomal biogen-
esis, as well as small ncRNAs such as microRNAs and
piwi-associated RNAs that control mRNA stability and
addition, lncRNAs play key functional roles in control-
ling cellular regulation [18,19,33-37], likely through their
interactions with diverse classes of proteins [18,19]. To
date, the full spectrum of proteins that interact with
ncRNAs is still unknown [13,14].
The past decade has seen a strong interplay between
method development, exploration and discovery about
RNA biology. The methods for exploring RNA-protein
interactions can be split into two general categories:
‘protein-centric’ and ‘RNA-centric’ methods. The protein-
centric methods generally rely on the ability to purify a
protein [38-40], or class of proteins [41], followed by se-
quencing of the associated RNAs to map RNA-binding
proteins (RBPs) across the transcriptome at high reso-
lution. Conversely, the RNA-centric approaches generally
capture a given RNA [42-44], or class of RNAs [45,46],
and identify the associated proteins using methods such
as mass spectrometry (MS).
Protein-centric approaches have been widely used to
generate binding maps of different RBPs across the tran-
scriptome and have provided important insights into
how mRNA processing is controlled in the cell
[21,23,47,48]. These methods have also been used to
gain initial insights into some of the proteins that can
interact with lncRNAs [49-51]. Because these methods
require knowledge of the protein, they are of more lim-
ited utility for defining the proteins that associate with a
given RNA transcript. The RNA-centric methods have
been more generally used to determine the complexes
associated with a specific ncRNA in the cell. Indeed, thel Ltd. The licensee has exclusive rights to distribute this article, in any medium,
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rg/licenses/by/2.0), which permits unrestricted use, distribution, and
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plexes, including those of telomerase RNA [42], small
nuclear RNA [43], 7SK RNA [44] and RNase P [52],
have been identified using these approaches.
In this review, we discuss approaches for identifying
RNA-protein interactions and the challenges associated
with interpreting these data. We describe the various
protein-centric methods, including native and crosslinking-
based methods, and explore the caveats and considerations
required for designing, performing and interpreting the re-
sults of these experiments. We describe approaches that
have been developed to account for analytical biases that
can arise in these data. Furthermore, we describe the vari-
ous RNA-centric methods for the identification of un-
known RNA-binding proteins, including the various RNA
tags used, purification schemes and detection methods.
While conceptually simple, the RNA-centric methods are
still not as common as the protein-centric methods be-
cause they require an extraordinary amount of starting ma-
terial to purify enough protein required for detection [53].
We describe the challenges associated with these methods
and their interpretation. Finally, we discuss the future steps
that will be needed to synthesize the results of these com-
plementary approaches and enable the systematic applica-
tion of such methods to new classes of ncRNAs.
Protein-centric methods to study RNA-protein
interactions
The predominant methods for examining RNA-protein
interactions are based on protein immunoprecipitation.
These methods generally utilize antibodies to pull down
the protein of interest and its associated RNA, which is
reverse transcribed into cDNA, PCR amplified and se-
quenced [38,54-59]. Bioinformatic analysis is then used
to map reads back to their transcripts of origin and iden-
tify protein binding sites [60,61].
There are several variants of these methods, which can
be broken down into two main classes: native
[39,40,51,58,62-64] and fully denaturing purifications
[22,55-57,59,65] (Figure 1a).
Native purifications
Native purification methods, often known simply as RIP
(RNA immunoprecipitation), purify RNA-protein com-
plexes under physiological conditions. The advantage to
these methods is that they preserve the native complexes
present in the cell. Yet, these methods also have several
limitations. The first and perhaps best described is due
to the non-physiological formation of RNA-protein in-
teractions in solution. Indeed, it has been shown that
purification of an RNA-binding protein can retrieve
RNAs, even when the RNA and protein are not present
in the same cell type and therefore could not be interact-
ing in vivo [66]. Furthermore, the RNAs that are purifiedare generally very well correlated with the abundance of
the RNA, with ribosomal RNAs being the largest con-
taminating RNA species in virtually all protein purifica-
tions [38]. As a consequence, specific interactions that
occur with low abundance transcripts may be masked by
non-specific interactions that occur with highly abun-
dant transcripts [38].
Because of these issues, there has been some contro-
versy about the nature of the interactions detected by
these methods. For example, many lncRNA-protein in-
teractions have been explored using native purifications
of proteins such as those found in Polycomb repressive
complex 2 (PRC2) [51,58,62]. In these studies, a very
large percentage of lncRNAs, as well as mRNAs, were
identified as interacting with PRC2 [58], with a recent
study arguing that virtually all transcripts interact with
PRC2 in the cell [62]. This has led to debate over the
biological significance of lncRNA-PRC2 interactions,
with some arguing that they are simply non-specific in-
teractions [67]. However, it is clear that at least some
lncRNAs interact with PRC2 [49,50,68] and that these
interactions have clear functional roles [58,69,70]. While
it is clear that both native and denaturing purification
methods can identify a similar core set of functional in-
teractions [71], the extent to which non-specific interac-
tions are also identified by the native methods remains
unclear. As such, interactions identified using native
purification methods often require further experimental
validation, such as through the integration of multiple
distinct experimental approaches [49,71,72].
Denaturing methods for RNA-protein interactions
To account for these concerns, denaturing methods
were introduced. By crosslinking RNA-protein com-
plexes in the cell and purifying the complex under de-
naturing conditions, one can distinguish in vivo
interactions that are crosslinked in the cell from interac-
tions that form subsequently in solution.
The dominant method for crosslinking RNA-protein
complexes is treatment of cells with short wavelength
UV light to create a covalent linkage between physically
interacting RNA and protein molecules in the cell, but
not between interacting proteins [73]. Methods such as
crosslinking and immunoprecipitation (CLIP) purify an
RNA-protein complex using stringent wash conditions
followed by denaturation of all complexes by heating in
sodium dodecyl sulphate (SDS), running the samples on
an SDS-polyacrylamide gel electrophoresis (PAGE) gel,
and extracting the crosslinked RNA-protein complex,
which will run at a size slightly larger than the protein
itself, from the gel [74,75]. The main limitation of this
method is the low efficiency of UV crosslinking. To ac-
count for this, a variant that significantly increases cross-
linking efficiency while retaining the main features of
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Figure 1 Protein-centric methods for detecting RNA-protein interactions. (a) Schematic of native and denaturing methods. RNA-protein
crosslinks are represented by red Xs. Non-specific interactions in solution are labeled (NS) and represented by blue RNA fragments. (b) Computa-
tional considerations for identification of interaction sites. The top panel depicts two transcripts - one low-abundance and one high-abundance -
that both contain a region that is twofold enriched in the immunoprecipitated (IP) sample over a control. Enrichment measurements in the low-
abundance case suffer from high variance. The bottom panel shows simulated enrichment values in a low-abundance region and a high-
abundance region, which both have a twofold enrichment in the IP sample. For the low abundance region, the observed log-fold changes are
often far from the true underlying value while the abundant transcript shows a more consistent enrichment estimation. (c) A schematic of
methods for mapping the precise protein binding sites on RNA. PAR-CLIP takes advantage of U → C transitions induced by UV crosslinking after
4SU incorporation. iCLIP uses the occasional arrest of reverse transcription at crosslink sites and tags and sequences these positions. CRAC relies
on reverse transcription errors (deletions and substitutions) at crosslink sites to map sites. CRAC, cross-linking and analysis of cDNA; iCLIP,
individual-nucleotide resolution cross-linking and immunoprecipitation; PAR-CLIP, photoactivatable-ribonucleoside-enhanced cross-linking
and immunoprecipitation.
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ribonucleoside-enhanced (PAR)-CLIP [56]. This ap-
proach incorporates a nucleotide analog (such as 4′-
thiouracil) into cells, followed by treatment of the cells
with long-wavelength UV. The drawback to this ap-
proach is that it is only amenable to cells in culture and
cannot be applied to primary tissues.
A significant concern with using UV crosslinking
methods is that they may miss real RNA-protein interac-
tions simply because they are not efficiently captured by
UV crosslinking. Indeed, several RBP families that do
not directly interact with nucleic acid bases but instead
interact with other features, such as the sugar phosphate
backbone, have been shown to have lower crosslinking
efficiency with UV [76]. Because UV-inducedcrosslinking is still incompletely understood at the bio-
physical level [38], it is unclear which types of interac-
tions might be missed or what frequency of real
interactions may be missed. In addition, because UV
only crosslinks direct RNA-protein interactions, it will
not capture interactions that occur through a complex
of multiple proteins. As an example, interactions with
many chromatin regulatory proteins have proven chal-
lenging to identify by purification under denaturing con-
ditions after UV crosslinking, likely because the precise
protein that interacts directly with RNA is still unknown
[33].
Other crosslinking methods, such as formaldehyde,
can eliminate the need to know the directly interacting
protein, but alternative denaturing strategies are needed
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would not resolve at the size of the protein. An alterna-
tive approach that leverages many of the conceptual fea-
tures of the CLIP method is to utilize direct denaturing
conditions rather than separation through an SDS-PAGE
gel. These methods use affinity tags coupled to the pro-
tein of interest for capture by purification in denaturat-
ing conditions (that is, using urea or guanidine) [59-65].
The advantage to this approach is that it can be used
with any crosslinking protocol, including formaldehyde
crosslinking, which otherwise could not be separated on
an SDS-PAGE gel [59]. Yet, this approach requires the
ability to express a tagged version of the RBP of interest
in the cell.
Analysis of protein-centric RNA-protein interaction data
There are two primary goals in the analysis of protein-
centric experiments: defining which RNAs are bound by
the specific protein and defining the specific protein-
binding sites on these RNAs.
It is important to compare the sample to a negative
control since observing reads from a specific RNA alone
may not be indicative of a real interaction. One control
is to normalize the coverage level of an RNA observed
after purification to its abundance in total lysate. Yet,
this control only accounts for issues due to RNA abun-
dance: interactions can occur due to association with the
purification resin or other features of the system. To ac-
count for this, other proteins can be used as negative
controls. However, the negative control should be se-
lected with care, as a non-RNA-binding protein is likely
to have lower non-specific RNA binding. Indeed, simply
mutating the RNA-binding domain of a protein has been
shown to remove both specific and non-specific interac-
tions formed by a protein [77]. The ideal control is to
demonstrate that the interaction is not present in the ab-
sence of crosslinking [22,38]. However, this control can
only be used in conjunction with a fully denaturing
protocol.
Furthermore, comparing the sample with a negative
control requires proper statistical methods because the
inherently low denominator for low abundance RNAs
will lead to a higher variance in the enrichment meas-
urement (Figure 1b). This challenge is similar to the
problems faced when computing differential expression
using RNA-Seq data [78], and many different statistical
solutions, including parametric, non-parametric and per-
mutation methods, have been proposed [79-81].
The second goal is to map protein-binding sites on
RNA. A major consideration is the size of the RNA after
digestion. While in theory the ideal size is that of the
protein footprint itself, several considerations favor
slightly larger sizes. One issue is the alignability of the
sequencing reads, as very small fragments may not beable to be uniquely aligned to the transcriptome. An-
other concern is that overdigestion may lead to a loss of
real binding sites by preferentially eliminating certain
protein footprints [75].
Because UV-crosslinking is irreversible, reverse tran-
scription can halt at the site of crosslinking even after
protein removal [22,25]. While this was originally con-
sidered a disadvantage of UV crosslinking, it has been
successfully used by several methods, including the CLIP
variant individual-nucleotide resolution CLIP (iCLIP), to
identify protein-binding sites on RNA with improved
resolution [55,57]. In addition to RT stops, crosslink sites
also show a higher rate of deletions and mismatches -
these have also been used to identify binding sites [61]
(Figure 1c). Yet, great care must be exercised when
interpreting these RT-induced stop sites and errors, as
RNA damage due to UV light is also known to inhibit
reverse transcription [82].
RNA-centric methods
Protein-centric methods are of limited utility for identi-
fying novel RBPs that interact with a specific RNA or for
the characterization of novel classes of ncRNAs for
which the identities of the RNA-binding proteins are still
unknown. An alternative approach is to use an RNA-
centric protein identification strategy. The general idea
is simple: rather than using an antibody to capture a
protein of interest and sequencing the associated RNA,
these methods purify an RNA of interest and identify
the associated protein complexes, using methods such as
MS. We will explore the different variants of these
methods below, focusing on those designed to compre-
hensively identify novel RNA-protein interactions.
RNA affinity capture methods
One general approach to capture RNA is to exploit nat-
urally occurring interactions between RNA and protein -
such as the bacteriophage MS2 viral coat protein, which
binds tightly to an RNA stem loop structure [83]. In this
approach, repeats of the MS2-binding RNA stem loop
are appended to an RNA of interest and the tagged RNA
complex is purified by coupling the MS2 protein to a
solid support or resin [84-86]. These dual component in-
teractions can be optimized to enable increased affinity
and stability [44,87]. As an example, a recent approach
makes use of an engineered Csy4 protein, a component
of the bacterial clustered regularly interspaced short pal-
indromic repeats (CRISPR) system, to generate a tag
with higher affinity than can be achieved for traditional
RNA tags, including MS2 and PP7 [87]. Alternatively, ar-
tificially designed RNA aptamers can be developed and
selected for binding to commonly used resin-conjugated
proteins [43,88]. An example of this is the S1 aptamer
that binds to streptavidin [89,90].
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exploited when trying to elute their respective RNA-
protein complexes. In general, protein complexes are
eluted from a support resin by boiling in SDS [87]. This
approach will dissociate bound material from the resin,
including complexes bound specifically through the tag
and those bound non-specifically directly to the resin.
For several of these affinity tags, complexes can be
eluted more specifically. For example, in the case of the
S1 aptamer, the weaker affinity of the S1-streptavidin
interaction compared with the biotin-streptavidin inter-
action can be exploited to enable specific elution of theCrosslinking in cellsTagged RNA
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cellular extracts [43,88,90]. In contrast, the in vivo ap-
proaches capture the RNA-protein complexes present in
the cell [45,46,85,92]. While the in vivo methods pre-
serve the context of true RNA-protein interactions, they
are more technically challenging, especially if the target
RNA is of low abundance in the cell.
Similar to the protein-centric methods, purification of
RNA under native conditions can lead to re-association
or formation of non-specific RNA-protein interactions
in solution. Studies using in vitro approaches or per-
forming purifications in native conditions have generally
found association between the RNA of interest and
highly abundant proteins in the cell, such as hnRNPs
[85,91,92]. Whether these represent real biological inter-
actions or non-specific associations is unclear because
only a handful of RNAs have been purified to date. To
address this, a recent study made use of UV crosslinking
and purified RNA complexes under fully denaturing
conditions (using 8 M urea), which will only capture
in vivo crosslinked complexes [85]. Using this approach,
there were clear differences in the proteins identified
after purifications performed in native and denaturing
conditions. DNA-binding proteins and other abundant
nucleic acid-binding proteins were present only in the
native purification, but not in the denaturing purifica-
tion, suggesting that at least some of these purified pro-
teins might be due to non-specific association in
solution. Other approaches use stringent, high-salt wash
conditions to reduce non-specific interactions during
RNA-protein complex purification [45,93,94].
The challenge with denaturing approaches is that they
require complexes to be crosslinked in the cell, which is
not efficient. In addition, several crosslinking strategies,
such as formaldehyde crosslinking, may have additional
technical challenges associated with the identification of
crosslinked peptides by MS [95].
Defining the proteins that associate with an RNA
We will focus on MS methods for identification of
RNA-binding proteins. There are two principal ways that
have been used to comprehensively identify these pro-
tein complexes by MS: non-quantitative and quantitative
MS (Figure 2b).
In the non-quantitative methods, purified proteins
from the RNA sample of interest and a control are sepa-
rated by gel electrophoresis and stained for total protein.
Protein bands that are present only in the sample of
interest but not the control are extracted and the pro-
teins identified by MS [84]. Alternatively, the total prote-
ome can be analyzed by MS to detect all proteins
purified in a sample [87,96]. The advantage to the latter
approach is that all proteins can be identified in the
sample, including those that are not visible on the gel. Inthis approach, the control can also be analyzed to iden-
tify non-specific proteins for exclusion. However, it is
difficult to directly compare the quantities of proteins
identified in the sample and control, due to variations in
the relative intensity of identified peptides in independ-
ent runs [53].
To overcome this limitation, one can use quantitative
MS to simultaneously compare the proteins in the sam-
ple and control. There are several ways to do this
(reviewed in [53]). In one popular method used for
RNA-protein analysis, cells are metabolically labeled to
generate differentially tagged protein pools for MS ana-
lysis, in which the isotopes of the proteins are compared
to provide direct quantification [97]. The advantage to
this approach is that the ratios of peptides from the ex-
perimental and control samples can be directly com-
pared to allow discrimination of true binding partners
from non-specific interactors. This method can account
for some of the issues associated with abundant protein
association. As an example, in quantitative MS experi-
ments, most of the abundant proteins, such as hnRNPs,
show equal abundance in both experimental and control
samples, suggesting that these interactions are not spe-
cific to the RNA of interest [91].
The choice of which MS approach to use for the iden-
tification of RBPs depends on the nature of the upstream
purification. When utilizing a protocol where the result-
ing protein purification yields little background in the
control sample, a non-quantitative approach may work
well. The CRISPR-Csy4 system, for instance, was previ-
ously shown to enable very high stringency and specific
elution, and because of this a non-quantitative approach
provided reliable results [87]. Similarly, when employing
crosslinking followed by a denaturing purification
strategy, non-quantitative MS might provide a good ap-
proach. In contrast, when using a system with higher
background, a quantitative MS approach can provide in-
creased ability to discriminate between specific and non-
specific binders.
Analytical challenges with RBP MS analysis
There are several analytical challenges for identifying
proteins associated with an RNA by MS. Similar to the
protein-centric methods, great care must be taken to se-
lect informative negative controls for the RNA-centric
methods. Controls that are often used include a different
cellular RNA [92], sequences lacking known protein-
binding structures [85-91], tag-only controls [44], anti-
sense RNA [71,98] or non-specific RNA sequences [99].
In these cases, any non-specific protein interactions due
to abundance, nucleic acid binding or the tag itself
should be identical for the target RNA and controls.
However, the ideal negative control is not clearly estab-
lished because there may be some specific features of
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proteins. In cases where protein-RNA crosslinking is
employed, the ideal control would be a non-crosslinked
sample because it represents the identical purification of
the same RNA but without any in vivo crosslinked com-
plexes [96]. However, this approach requires the use of
in vivo crosslinking followed by a denaturing purification
and therefore is not applicable to all purification
methods. In the absence of this, several different nega-
tive controls should be included to ensure robustness of
the results identified.
A significant challenge in the identification of un-
known RBPs is the generation of sufficient material for
MS, particularly for low abundance RNA-protein com-
plexes. Unlike sequencing methods that enable nucleic
acid amplification, the amount of protein purified in
these experiments cannot be amplified. For this reason,
RNA-centric methods have mostly been applied to
highly abundant RNAs, such as 7SK [44], snRNPs [100],
Let-7 [99] and IRES [85]. More recently, these ap-
proaches have been used to define proteins associated
with all mRNA by UV crosslinking RNA-protein com-
plexes, capturing polyadenylated transcripts using oligo-
dT coupled magnetic beads, and detecting associated
proteins by quantitative MS [45,46,94]. Yet, application
of this approach to identify binding partners of individ-
ual mRNAs, lncRNAs or other low abundance RNAs is
still a significant challenge.
Future directions
While much work has been done to develop methods to
identify and examine RNA-protein interactions, there
are still significant challenges that need to be addressed.
To date, we still do not know the protein complexes that
interact with most RNAs in the cell - including mRNAs,
classical ncRNAs and lncRNAs. For lncRNAs in particu-
lar, we know little about the diversity of proteins that
they may interact with. Many of the protein complexes
that have been identified to interact with lncRNAs do
not fall into traditional RNA-binding protein classes,
making it difficult to generate accurate predictions of
what these complexes may look like. Understanding the
protein complexes that interact with lncRNAs will be an
important first step toward understanding their various
biological functions and mechanisms. The major chal-
lenge with defining these proteins is that the RNA-
centric methods are still not well suited for exploring
low abundance transcripts. Future work will be needed
to address this challenge and to define the protein com-
plexes that interact with a given lncRNA or individual
mRNA.
Although the development of the protein-centric and
RNA-centric approaches has mostly proceeded independ-
ently, we can now begin to combine the results of thesecomplementary approaches to build a complete picture of
the repertoire of RBPs in a cell and define their roles in
binding and modulating the functions of various classes
of RNA [101]. Several recent studies have begun to
examine protein binding at a transcriptome-wide scale
[45,94,102-106]. In these studies, RBPs [45,94,102,104]
and/or their binding sites [45,94,102-106] have been iden-
tified by MS or high-throughput sequencing, respectively.
By exploring the different components of RNA-protein
complexes, we will be able to identify new RBPs, as well as
discriminate the timing of the binding of a set of given
RBPs to an individual RNA [107]. This will ultimately pro-
vide a more complete understanding of the function of
RNA-protein complexes, including how these complexes
assemble and how they modulate cellular function.
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